| 000 | 01241 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511185744.0 | ||
| 264 | 0 | _c19930216 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerry, W R | |
| 245 | 0 | 0 |
_aResults of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cDec 1992 |
||
| 300 |
_a33-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOndansetron _xadministration & dosage |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aHouse, K W | |
| 700 | 1 | _aLee, J T | |
| 700 | 1 | _aPlagge, P B | |
| 700 | 1 | _aMeshad, M W | |
| 700 | 1 | _aGrapski, R | |
| 773 | 0 |
_tSeminars in oncology _gvol. 19 _gno. 6 Suppl 15 _gp. 33-7 |
|
| 999 |
_c1491666 _d1491666 |
||